The program includes updates about several regional and international initiatives on the use of transgenic animals in research and the innovative use of
targeted nucleases and their applications in transgenic animals.
In this post we'll walk through a variety of ways you can use AAVs to improve your genome editing experiments (with and without
targeted nucleases).
In an effort to combine the respective advantages of the AAV and CRISPR - based approaches, several groups have recently worked to enhance the efficiency of AAV - based gene editing via the introduction of a double strand break by using
a targeted nuclease.
Not exact matches
«CRISPR has proven so easy and inexpensive that Dana Carroll of the University of Utah, Salt Lake City, who spearheaded the development of zinc finger
nucleases, [one of its competitors,] says it has brought about the «democratization of gene
targeting.
By using engineered zinc - finger
nucleases (ZFNs) designed to
target an integrated reporter and two endogenous rat genes, Immunoglobulin M (IgM) and Rab38, we demonstrate that a single injection of DNA or messenger RNA encoding ZFNs into the one - cell rat embryo leads to a high frequency of animals carrying 25 to 100 % disruption at the
target locus.
GUIDE - seq enables genome - wide profiling of off -
target cleavage by CRISPR - Cas
nucleases.
Furthermore, by adding guanine nucleotides at the end of sgRNA (single guided RNA) that composes CRISPR - Cas9, they have successfully created this highly - developed programmable
nuclease, which has no measurable off -
target effects in the human genome.
But CRISPR has proven so easy and inexpensive that Dana Carroll of the University of Utah, Salt Lake City, who spearheaded the development of zinc finger
nucleases, says it has brought about the «democratization of gene
targeting.»
One concern, for example, is that the
nucleases could cause mutations at locations other than those
targeted.
Shown to work just 3 years ago, CRISPR consists of a an enzyme called a
nuclease and a piece of RNA that homes in on a
targeted DNA sequence, enabling the enzyme to introduce precisely
targeted mutations, corrections to mutations, or other alterations.
Just this week, for example, a team led by Feng Zhang of the Broad Institute of Harvard and MIT, one of the pioneers of the method, published a paper in Science on engineering the
nuclease part of CRISPR so that it more accurately cuts the intended DNA
target.
What's more, say the researchers, the cancer - causing effects of off -
target deletions mistakenly created by the V (D) J enzyme need to be considered in designing site - specific enzymes for genome modification such as zinc - finger
nucleases, TALENS, or CRISPRs.
«Research team evolves CRISPR - Cas9
nucleases with novel properties: Engineered variants of gene - cutting enzyme double the
targeting range, reduce off -
target effects.»
Last year, researchers
targeted and destroyed this gene in the T - cells of 12 people with HIV using custom - made proteins called zinc finger
nucleases.
Known to be highly effective, genome editing using «artificial
nuclease» aims to cut the DNA at the
target point and to modify the gene while it is repaired.
Cell growth was monitored every 48 hours post-stimulation for approximately two weeks and the efficiency of CXCR4 disruption was assessed at day five post-transduction by both the Surveyor
nuclease assay and by deep - sequencing of the CXCR4
target site.
Upon binding of both X4 - ZFNs, the FokI
nuclease cleavage domains dimerize and then generate a double strand break that can subsequently be repaired by error - prone NHEJ resulting in mutations
targeted to the cleavage site that can include missense mutations, deletions and insertions (Figure 1).
His work also contributed to advance the use of artificial
nucleases for
targeted genome editing in cell and gene therapy.
Through careful mapping of the ribose requirements of Cas9, we develop hybrid versions possessing minimal RNA residues, which are sufficient to direct specific
nuclease activity in vitro and in vivo with reduced off -
target activity.
Science magazine heralded these transcription activator - like effector
nuclease proteins, known as TALENS, as a major scientific breakthrough in 2012, nicknaming them «genomic cruise missiles» for their ability to allow researchers to
target specific locations with great efficiency.
In MMEJ pathway, we achieve efficient gene disruption in human cell lines and animals by developing a computer program that assists the choice of
nuclease target sites based on microhomology prediction.
Digenome - seq is an in vitro
nuclease - digested whole - genome sequencing to profile genome - wide
nuclease off -
target effects in cells.
Please note that this off -
target score is available for human genome with SpCas9
nucleases.
The Swiss team's cool idea was to make a CRISPR / Cas machine that
targets the huntingtin gene — but with an extra CRISPR sequence that also makes the Cas
nuclease target its own DNA.
Development of Knock out (KO) technologies
targeted via TALE
nucleases, CRISPR and meganucleases
software for analysis of PGM sequencing of DNA
targeted with artificial sequence - specific
nucleases
In a second scheme, transcription activator - like effector
nucleases (TALENs) were
targeted to sequences near the translation - initiation site of CCHa2 - R to create a frame - shift mutation in the CCHa2 - R coding region [24].
Zinc finger
nucleases [1], [2], transcription activator - like effector
nucleases [3], [4] and homing meganucleases [5] have provided powerful tools to induce
targeted mutations in the form of small insertions or deletions derived from DNA break repair of nonhomologous end joining (NHEJ) or homologous recombination.
Efficient gene
targeting of the Rosa26 locus in mouse zygotes using TALE
nucleases.
These systems, however, require efficient design and time - consuming assembly of
nuclease constructs for DNA
targeting.
A patent application has been filed and testing is underway on the protein — called HT - TALENs (short for HIV -
targeted transcription activator - like effector
nucleases)-- which uses a newly developed gene - editing technique to rid the body's cells of the immunodeficiency virus before it has a chance to multiply and possibly develop into AIDS.